Skip to main content
AORT
NYSE Life Sciences

Q3 Revenue Up 9% but Adjusted EBITDA Falls 8% as Artivion Narrows Guidance

Tom Rudovsky · Reported by PR Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$25.33
Mkt Cap
$1.235B
52W Low
$19.16
52W High
$48.25
52W Position info
32% above low
Off High info
48% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

AORT sits 32% above its 52-week low of $19.16 on elevated volume (1.8× avg).

Summary

Revenue rose 9% to $123.8 million, beating analyst expectations on On-X growth, but the quality of the quarter was weak: GAAP swung to a $(7.9) million net loss, or $(0.16) per share, from $6.5 million of income a year ago, and adjusted EBITDA fell 8% to $22.5 million. Non-GAAP net income of $3.8 million ($0.08 per share) was half last year's $7.9 million. Management narrowed full-year 2026 revenue guidance to $484-492 million (8-10% constant-currency growth) from $480-496 million, and adjusted EBITDA to $93-98 million from $92-99 million. The bull case rests on the AMDS and NEXUS PMAs and the January 2027 NEXUS U.S. launch, with a first surgeon training event in December; the near-term problem is margin pressure from Endospan integration costs and a $363.8 million debt load against $48.4 million of cash.

At the time of this announcement, AORT was trading at $25.33 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $19.16 to $48.25. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

AORT - Latest Insights

AORT
Aug 07, 2026, 1:57 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $27.52
Real-time Price: $25.33 info
Change: -$2.19 (-8%) info
Market Cap: $1.235B info
AORT
Aug 06, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.77
Real-time Price: $25.33 info
Change: -$1.44 (-5%) info
Market Cap: $1.235B info
AORT
Jun 29, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $23.78
Real-time Price: $25.33 info
Change: +$1.55 (+7%) info
Market Cap: $1.235B info
AORT
May 18, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.54
Real-time Price: $25.33 info
Change: +$1.79 (+8%) info
Market Cap: $1.235B info
AORT
May 08, 2026, 10:56 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $25.55
Real-time Price: $25.33 info
Change: -$0.220 (-0.86%) info
Market Cap: $1.235B info